E whakaatu ana te pūrongo hou a te #WHO mō te mate kohi i tētahi mea tino pono: 8.2 miriona ngā kēhi hou o te mate kohi i kitea i te tau 2023—ko te mea teitei rawa atu mai i te tīmatanga o te aroturukitanga ā-ao i te tau 1995. Nā tēnei pikinga mai i te 7.5 miriona i te tau 2022 ka whakahokia mai te mate kohi heite kaikōhuru matua mō ngā mate pipiri, e hipa ana i te COVID-19.
Heoi anō, kei te atarangi tēnei aranga anō e tētahi raruraru kino rawa atu:te ātete ki ngā huakita (AMR)E matapaetia ana e te WHO, tae noa ki te tau 2050, ka taea e te AMR te kītae atu ki te 10 miriona oranga ia tauputa noa i te ao, ko te mate kohi ātete-rongoa (DR-TB) te take nui. I te tau 2019 anake, i mate tika te 1.3 miriona tāngata i te AMR—neke atu i te HIV/AIDS me te malaria i te whakakotahitanga—ā, koia nei tete tuatoru o ngā take mate nui o te aoKi te kore he wawaotanga, ka eke pea ngā mate tāpiri mai i te AMR ki te taumata teitei ake.39 miriona i te tau 2050, me ngā mate ōhanga e nui rawa atu ana$100 tiriona.
He aha te take e kore ai e taea te whiriwhiri i te tātaritanga wā tika
Ko te kaha o te rongoā mō te mate kohi kei te kitea wawe me te tika o ngā tikanga rongoā. Heoi, nā te whakamahinga hē o ngā paturopi kua tere ake te mate kohi ātete-maha-rongoā (MDR-TB), ā, kua huri ngā mate ka taea te rongoā hei tūmomo mōrearea whakamate. He mea whakamataku:
Ko te mate kohi ātete-rongoa te take o te 1/3 o ngā mate AMR o te ao.
Kei te piki haere te mate o ngā tāngata kua kaumātuatia mō ngā AMR(kua piki ake i te 80% mai i te tau 1990 i waenga i ngā kaumātua).
Tērā pea ka rerekē te āhuarangika kino ake te horapa o te AMR mā te 2.4% i te tau 2050, he pānga nui ki ngā rohe rawakore.
Kei te karanga tere a WHO mō ngā mahi auaha i roto i te tātaritanga tere hei whawhai i te whakamahi hē me te whakakī i ngā āputa maimoatanga
Kete TB Toru kua Tiwhikete CE a Macro & Micro-Test: Ngā Utauta Tika mō te Wā AMR
E hangai ana tā mātou otinga ki te rautaki aukati AMR a te WHO mā te whakahohe ite kitenga i te mate TB me te ātete ki te rifampicin (RIF) me te isoniazid (INH) i te wā kotahi—he mea nui hei whakaiti i te mate urutā DR-TB.
Ngā Āhuatanga Matua:
Tere me te TikaKa puta ngā hua i roto i te 2–2.5 hāora me te whakamaoritanga aunoa (he iti noa te whakangungu e hiahiatia ana).
Ngā Whāinga Whānui:TB: Ira IS6110
Ātete RIF: rpoB (507~533)
Ātete INH: InhA, AhpC, katG 315
Teitei o te TairongoKa kitea te iti rawa o te 10 huakita/mL (TB) me te 150–200 huakita/mL mō ngā tohu ātete.
E tutuki ana i ngā whakaritenga a te WHO: E tutuki ana i ngā aratohu mō te whakahaere i te DR-TB.
Hototahi WhānuiKa mahi tahi me ngā pūnaha PCR matua (hei tauira, Bio-Rad CFX96, SLAN-96P/S).
He aha te Hiranga o tēnei:
Mā te tere o te tautuhi i ngā ira ātete ka ārai i te whakamahinga koretake o ngā paturopi, ka whakaiti i te tuku,
Karanga ki te Mahi
Ko te huihuinga o te hokinga mai o te mate kohi me te AMR e hiahia ana ki ngā taputapu e hono ana i te tere me te tika. Ka whakakapihia tēnei āputa e tā mātou kete—kia tika ai te tīmatanga o te maimoatanga, i te wā tuatahi.
Ako atu:
https://www.mmtest.com/mycobacterium-tuberculosis-nucleic-acid-and-rifampicin%ef%bc%8cisoniazid-resistance-product/
Whakapā mai:marketing@mmtest.com
#IVD #PCR #AMRCrisis #Ātete ki te Rongoā #TB #ENDTB #MDRTB #Tautoko #HauoraAo #WHO #MacroMicroTest
Wā tuku: Whiringa-ā-rangi 25-2025